Sign in

CIK 0001604821 · Large accelerated filer

Natera, Inc.

Sign in to watch
Ticker
NTRA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
010894487
Phone
650-249-9090
Business address
13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
Former names
Natera, Inc.
  1. 4 Planned sale Director sold 6,144 shares at an average $234.60 ($1,441,367)
  2. 4 Planned sale SEC. AND CHIEF LEGAL OFFICER sold 19,672 shares at an average $234.74 ($4,617,888)
  3. 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 23,498 shares at an average $234.74 ($5,515,960)
  4. 4 Planned sale PRESIDENT, CHIEF BUS. OFFICER sold 18,145 shares at an average $234.74 ($4,259,417)
  5. 144 Insider Sale of Securities
  6. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 59,596 shares (grant or award)
  7. 4 Grant or award CEO AND PRESIDENT acquired 152,718 shares (grant or award)
  8. 4 Grant or award PRESIDENT, CHIEF BUS. OFFICER acquired 44,698 shares (grant or award)
  9. 4 Grant or award PRESIDENT, CLINICALDIAGNOSTICS acquired 44,698 shares (grant or award)
  10. 4 Grant or award SEC. AND CHIEF LEGAL OFFICER acquired 37,248 shares (grant or award)
  11. 4 Grant or award Director acquired 7,450 shares (grant or award)
  12. 8-K Event Results of operations
  13. 4 Option exercise Director acquired 39,615 shares (option exercise)
  14. 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 2,951 shares at an average $228.95 ($675,621)
  15. 4 Planned sale CEO AND PRESIDENT sold 3,848 shares at an average $229.08 ($881,482)
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 4 Planned sale Director sold 1,500 shares at an average $225.94 ($338,914)
  19. 144 Insider Sale of Securities
  20. 4 Planned sale Director sold 3,070 shares at an average $227.01 ($696,912)

Page 14 of 94 · 1,862 filings